Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause
AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause


AbCellera (Nasdaq: ABCL) today announced it has received a No Objection Letter (NOL) from Health Canada authorizing its Clinical Trial Application (CTA) for ABCL635, an investigational antibody

Oceaneering to Participate at Citi’s 2025 Spotlight on SMID Energy Day
Oceaneering to Participate at Citi’s 2025 Spotlight on SMID Energy Day


Oceaneering International, Inc. ("Oceaneering") (NYSE:OII) announced today that Senior Vice President and Chief Financial Officer Alan R. Curtis and Senior Investor Relations Director Hilary

GeoPark Provides Update on Transaction in Vaca Muerta, Argentina
GeoPark Provides Update on Transaction in Vaca Muerta, Argentina


GeoPark Limited (“GeoPark” or the “Company”) (NYSE: GPRK), a leading independent energy company with over 20 years of successful operations across Latin America, announces today that Phoenix Global

Cushman & Wakefield Hires Rich Okoney as Global Data Center Facilities Management Practice Lead
Cushman & Wakefield Hires Rich Okoney as Global Data Center Facilities Management Practice Lead


Rich Okoney has joined Cushman & Wakefield (NYSE: CWK) as Global Data Center Practice Lead in the firm’s Integrated Facility Management (IFM) Service Line team. Based in Connecticut, Okoney will

State Street Corporation Declares Dividends on its Common Stock and Non-Cumulative Perpetual Preferred Stock Series “G,” “I,” “J,” and “K”
State Street Corporation Declares Dividends on its Common Stock and Non-Cumulative Perpetual Preferred Stock Series “G,” “I,” “J,” and “K”


State Street Corporation (NYSE:STT) today announced a quarterly cash dividend of $0.76 per share of common stock, payable on July 11, 2025 to common shareholders of record at the close of business

Customers Bancorp, Inc. Announces Full Redemption of Series E Preferred Stock
Customers Bancorp, Inc. Announces Full Redemption of Series E Preferred Stock


Customers Bancorp, Inc. (NYSE: CUBI) is redeeming, in whole, all 2,300,000 shares ($57.5 million) of its Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series E (ticker “CUBIPrE”)

Xylem Inc. Declares Second Quarter Dividend of 40 Cents per Share
Xylem Inc. Declares Second Quarter Dividend of 40 Cents per Share


The Board of Directors of Xylem Inc. (NYSE: XYL), has declared a second quarter dividend of $0.40 per share payable on June 26, 2025, to shareholders of record as of May 29, 2025.



About Xylem

Jack in the Box Inc. Reports Second Quarter 2025 Earnings
Jack in the Box Inc. Reports Second Quarter 2025 Earnings


Jack in the Box Inc. (NASDAQ: JACK) announced financial results for the Jack in the Box and Del Taco brands in the second quarter, ended April 13, 2025.



“I am encouraged by our marketing plans in

Kohl’s Corporation Declares Quarterly Dividend
Kohl’s Corporation Declares Quarterly Dividend


The Board of Directors of Kohl’s Corporation (NYSE:KSS) (“Kohl’s” or the “Company”) today declared a regular quarterly dividend of $0.125 per share on the Company’s common stock. The dividend is

United Bankshares Declares Second Quarter Dividend
United Bankshares Declares Second Quarter Dividend


United Bankshares, Inc. (NASDAQ: UBSI) today announced that its Board of Directors declared a second quarter 2025 dividend of $0.37 per share for shareholders of record as of June 13, 2025.



The

PROS Unveils Revolutionary AI Agents to Transform Business Efficiency and User Engagement
PROS Unveils Revolutionary AI Agents to Transform Business Efficiency and User Engagement


PROS Holdings, Inc. (NYSE: PRO), a leading provider of AI-powered SaaS pricing and selling solutions, today announced the launch of PROS AI Agents. Showcased at the company’s Outperform with PROS

Chemed Corporation to Present at the 2025 RBC Global Healthcare Conference
Chemed Corporation to Present at the 2025 RBC Global Healthcare Conference


Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Global Healthcare Conference on Wednesday, May 21, 2025, at approximately 9:30 a.m. (ET) at The

MaaT Pharma To Present Updated Data for MaaT013 in Early Access Program at the European Hematology Association (EHA) Annual Congress
MaaT Pharma To Present Updated Data for MaaT013 in Early Access Program at the European Hematology Association (EHA) Annual Congress


Regulatory News:



MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to

EQS-News: Shelly Group off to a strong start in financial year 2025 – Growth slightly above expectations
EQS-News: Shelly Group off to a strong start in financial year 2025 – Growth slightly above expectations
EQS-News: Shelly Group off to a strong start in financial year 2025 – Growth slightly above expectations
EQS-Adhoc: Brockhaus Technologies AG: Q1 2025 quarterly statement publication postponed to May 30, 2025; audit opinions 2024 issued for three operating Bikeleasing Group companies
EQS-Adhoc: Brockhaus Technologies AG: Q1 2025 quarterly statement publication postponed to May 30, 2025; audit opinions 2024 issued for three operating Bikeleasing Group companies
EQS-Adhoc: Brockhaus Technologies AG: Q1 2025 quarterly statement publication postponed to May 30, 2025; audit opinions 2024 issued for three operating Bikeleasing Group companies
Results of the Ordinary General Meeting of Avolta AG held on May 14, 2025
Results of the Ordinary General Meeting of Avolta AG held on May 14, 2025
Results of the Ordinary General Meeting of Avolta AG held on May 14, 2025
Kohl’s Corporation Holds Annual Meeting of Shareholders
Kohl’s Corporation Holds Annual Meeting of Shareholders


Kohl’s Corporation (NYSE: KSS) (“Kohl’s” or the “Company”) today held its 2025 Annual Meeting of Shareholders. Below are the results of shareholder voting on the four proposals presented at the

123rd Annual General Meeting of Romande Energie Holding SA
123rd Annual General Meeting of Romande Energie Holding SA
123rd Annual General Meeting of Romande Energie Holding SA
Connection Announces 5th Annual IT Superhero Awards
Connection Announces 5th Annual IT Superhero Awards


Connection (PC Connection, Inc.; NASDAQ: CNXN), a leading provider of information technology solutions to business, government, healthcare, and education markets, proudly celebrates the 5th

Kaufman & Broad SA: ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF 2025, MAY 6TH - VOTING RESULTS
Kaufman & Broad SA: ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF 2025, MAY 6TH - VOTING RESULTS
Kaufman & Broad SA: ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF 2025, MAY 6TH - VOTING RESULTS
EQS-News: Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Candidate HDP-101 at EHA 2025
EQS-News: Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Candidate HDP-101 at EHA 2025
EQS-News: Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Candidate HDP-101 at EHA 2025
ArcBest Introduces Latest Vaux Vision Advancements and Key Leadership Progression
ArcBest Introduces Latest Vaux Vision Advancements and Key Leadership Progression


ArcBest® (Nasdaq: ARCB), an integrated logistics company, today announced progress on its initial Vaux VisionTM pilots, and the appointment of Brian Nachtigall as General Manager of Vaux, effective

Schrödinger to Present Phase 1 Clinical Data on MALT1 Inhibitor SGR-1505 at EHA Annual Congress and International Conference on Malignant Lymphoma
Schrödinger to Present Phase 1 Clinical Data on MALT1 Inhibitor SGR-1505 at EHA Annual Congress and International Conference on Malignant Lymphoma


Schrödinger, Inc. (Nasdaq: SDGR) today announced that initial Phase 1 clinical data for SGR-1505, its investigational MALT1 inhibitor, will be presented at the European Hematology Association

EQS-Adhoc: Bitcoin Group SE: Forecast for the 2024 financial year significantly exceeded
EQS-Adhoc: Bitcoin Group SE: Forecast for the 2024 financial year significantly exceeded
EQS-Adhoc: Bitcoin Group SE: Forecast for the 2024 financial year significantly exceeded